- Home
- MRNA vs MPWR Comparison
MRNA vs MPWR Comparison
Compare MRNA & MPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | MPWR |
|---|---|---|
| Founded | 2010 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6B | 64.5B |
| IPO Year | 2018 | 2004 |
Fundamental Metrics
Financial Performance| Metric | MRNA | MPWR |
|---|---|---|
| Price | $221.44 | $1,194.81 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 23 | 17 |
| Target Price | $138.37 | ★ $1,799.80 |
| AVG Volume (30 Days) | ★ 16.5M | 672.9K |
| Earning Date | 11-06-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 0.66% |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ 9.15 |
| Revenue | ★ $19,263,000,000.00 | $333,067,000.00 |
| Revenue This Year | $8.13 | $49.18 |
| Revenue Next Year | $16.26 | $27.98 |
| P/E Ratio | ★ N/A | $131.86 |
| Revenue Growth | 4.29 | ★ 17.89 |
| 52 Week Low | $22.28 | $833.18 |
| 52 Week High | $254.48 | $1,714.09 |
Technical Indicators
Market Signals| Indicator | MRNA | MPWR |
|---|---|---|
| Relative Strength Index (RSI) | 57.03 | 42.23 |
| Support Level | $45.39 | $1,133.83 |
| Resistance Level | $254.48 | $1,253.11 |
| Average True Range (ATR) | 23.18 | 49.95 |
| MACD | -3.74 | -10.88 |
| Stochastic Oscillator | 55.92 | 28.58 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About MPWR Monolithic Power Systems Inc.
Monolithic Power Systems is an analog and mixed-signal chipmaker specializing in power management solutions. Its mission is to reduce total energy consumption in end systems. It serves the computing, automotive, industrial, communications, and consumer end markets. MPS uses a fabless manufacturing model, partnering with third-party chip foundries to host its proprietary BCD process technology.